Showing results (11-20 of 91) with videos related to
Sort By:
Pageof 10
Clinical Neuroscience (New York, N.Y.)|April 29, 2000
Gastrointestinal dysfunction in Parkinson's diseaseR F PfeifferMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Dentatorubro-pallidoluysian atrophy of the myoclonus epilepsy type with posterior column degenerationR F Pfeiffer, R D McCombMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
"On-off"-induced lethal hyperthermiaR F Pfeiffer, E L SuchaCurrent Opinion in Neurology and Neurosurgery|June 1, 1992
Genetic considerations in movement disordersZ K Wszolek, R F PfeifferNeurochemistry International|December 1, 1992
Differential stimulation of hepatic and brain metallothioneins by ethanolM Ebadi, R F Pfeiffer, A HuffNeurochemistry International|December 1, 1993
The effects of 6-hydroxydopamine and oxidative stress on the level of brain metallothioneinH Shiraga, R F Pfeiffer, M EbadiNeuroscience Letters|November 17, 1995
Selegiline protects dopaminergic neurons in culture from toxic factor(s) present in the cerebrospinal fluid of patients with Parkinson's diseaseR Hao, M Ebadi, R F PfeifferAnnals of Neurology|April 1, 1985
Mesulergine (CU32-085) in the treatment of Parkinson's diseaseR F Pfeiffer, K Wilken, C GlaeskeComparative Biochemistry and Physiology. B, Comparative Biochemistry|February 1, 1993
Purification and characterization of metallothionein and its activation of pyridoxal phosphokinase in trout (Salmo gairdneri) brainR Hao, R F Pfeiffer, M EbadiThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1996
Descriptive epidemiology of Parkinson's disease through proxy measuresD Strickland, J M Bertoni, R F PfeifferPageof 10